Identification
- Composition (DCI)
- ticagrélor
- Manufacturer
- MAPHAR
- ATC code
- B01AC24
- Presentation
- Boite de 60
- Schedule / Reimb.
- A
- Hospital price
- 636.00 MAD
Indications
Brilique, en association avec l’acide acétylsalicylique (AAS), est indiqué dans la prévention des événements athérothrombotiques chez les patients adultes ayant : - un syndrome coronaire aigu (SCA) ou - des antécédents d’infarctus du myocarde (IdM) et à haut risque de développer un événement athérothrombotique.
Find an open pharmacy
On-call pharmacies near you
About BRILIQUE 90 MG
BRILIQUE 90 MG is marketed in Morocco by MAPHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of BRILIQUE 90 MG, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about BRILIQUE 90 MG
Answers to common questions from Moroccan patients about this drug.